Target intelligence / Profile preview

Human telomeric G-quadruplex DNA (hTel G4)

Target
hTel G4
Molecular classification
Nucleic acid, G-quadruplex, Non-canonical DNA structure
01

Overview

Human telomeric G-quadruplex DNA is a non-canonical secondary structure formed by the guanine-rich tandem repeats (TTAGGG) at the ends of human chromosomes [6, 7]. These structures are composed of stacked G-tetrads stabilized by Hoogsteen hydrogen bonds and monovalent cations, typically potassium or sodium [1, 6]. In most cancer cells, telomere length is maintained by the overexpressed enzyme telomerase, which prevents the natural senescence that occurs in somatic cells [3, 12]. Small molecule ligands designed to target and stabilize these G-quadruplexes can physically block telomerase access and displace protective shelterin proteins like POT1 [2, 13]. This uncapping of the telomere is recognized by the cell as a double-strand break, triggering a robust DNA damage response that leads to apoptosis or permanent growth arrest [2, 10]. As such, the human telomeric G-quadruplex represents a promising therapeutic target for broad-spectrum anticancer drug development [4, 8].

Other names
Telomeric G-quadruplexhTel G4Human telomeric G4Telomeric DNA G-quadruplexhTel-G4G4-DNA
02

Mechanism of action

Stabilization of the G-quadruplex structure at the 3' telomeric overhang, which inhibits telomerase-mediated telomere extension and displaces telomere-binding proteins such as POT1, leading to telomere uncapping, activation of the DNA damage response, and subsequent induction of apoptosis or senescence [2, 6, 10].

03

Biological functions

Telomere maintenanceTelomerase inhibitionChromosome end protectionDNA damage response inductionCellular senescence regulation
04

Disease associations

CancerAging
05

Safety considerations

Off-target effects on other genomic G-quadruplexesPotential for systemic toxicity in high-turnover healthy tissuesInduction of genomic instabilityChallenges in achieving high structural selectivity [4, 13]
06

Interacting drugs

BRACO-19

6 more in the full profile.

07

Biomarkers

Telomere lengthTelomerase activityhTERT expressionTelomere dysfunction-induced foci (TIFs)Gamma-H2AX

Beyond the preview

Go deeper on Human telomeric G-quadruplex DNA (hTel G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human telomeric G-quadruplex DNA (hTel G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call